Pharmaceutical Technology

APRIL 4, 2023

Indian pharma manufacturing continues to be the backbone of drug supplies worldwide, and GlobalData analysis suggests US overreliance on the country for generic drug supply. US reliance on India for generic drugs could have supply chain security and quality implications for critical medicines.

Manufacturing 130

Manufacturing Generic Drugs Contract Manufacturing Production 130

Pharmaceutical Technology

MAY 31, 2023

The therapeutic candidate targets immune checkpoint, programmed cell death protein 1 (PD1). The company also provides generic drugs and contract development and manufacturing services across its global network. It is administered as an intravenous infusion. It is developed based on sympress platform technology.

Generic Drugs 100

Generic Drugs Hormones Manufacturing Development 100

Pharmaceutical Technology

OCTOBER 28, 2022

To demonstrate bioequivalence for a generic small molecule drug, a company must carry out a Phase I clinical trial in healthy individuals to ensure that the area under the curve and maximum plasma concentration for their drug is equivalent to that of the brand name drug.

Bioequivalency 130

Bioequivalency Production Branding Contamination 130

pharmaphorum

DECEMBER 1, 2021

The French group said that ORI-001, a vaccine based on recombinant proteins from the Cutibacterium acnes (formerly Propionibacterium acnes ) bacterium that is often found in acne lesions, could be the first ever vaccine for the condition. C acnes is implicated in moderate to severe acne, which is difficult to treat.

Vaccination 100

Vaccination Vaccine Development Hormones 100

Cloudbyz

MARCH 5, 2024

Here’s an overview of the differences between them: Composition and Size : Small Molecules: These are chemically synthesized drugs that are generally low in molecular weight, typically less than 900 Daltons. Biologics: Biologics are large, complex molecules, often proteins, that are produced using living cells.

Development 77

Development Drugs Manufacturing Immune Response 77

XTalks

FEBRUARY 8, 2021

In order to fact-check some of these misconceptions, the US Food and Drug Administration (FDA) recently hosted a webinar on biosimilar and interchangeable biological products to help healthcare professionals understand more about these treatment options. Biosimilars are the “generic” drugs of the biopharma world.

Production 78

Production Insulin Branding Generic Drugs 78

XTalks

AUGUST 2, 2023

Stelara’s patents are expiring in September 2023, while a handful of biosimilar drugs are in late-stage development or seeking FDA approval. The FDA approved the drug over a decade ago in September 2009. billion the drug generated in 2021. Johnson & Johnson’s total global earnings from Stelara were $9.72

Sales 98

Sales Manufacturing FDA Approval Life Science 98